Go Deep
BioRestorative Therapies, Inc.
BioRestorative Therapies, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 23,694 | -0.1 | 0.67 | 0.01 | 138.28 |
| Oct 2026 | 23,664 | -0.1 | 0.70 | 0.01 | 145.86 |
| Oct 2026 | 21,441 | -0.1 | 0.73 | 0.01 | 151.71 |
| Oct 2026 | 21,454 | -0.1 | 0.71 | 0.01 | 147.91 |
| Oct 2026 | 21,465 | -0.1 | 0.70 | 0.01 | 144.71 |
| Oct 2026 | 21,476 | -0.1 | 0.69 | 0.01 | 141.59 |
BioRestorative Therapies, Inc. Quarterly Results
| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|
| Revenue | 23,170.0 | 19,600.0 | 11,800.0 | 303,300.0 |
| Net Profit | -2,154,405.0 | -3,207,636.0 | -3,038,277.0 | -2,656,263.0 |
| EPS | -0.1 | — | -0.3 | -0.3 |
BioRestorative Therapies, Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 359,700.0 | 401,000.0 | 145,800.0 | 119,800.0 | — |
| Net Profit | -14,241,975.0 | -8,979,381.0 | -10,417,704.0 | -13,222,296.0 | — |
| EPS | -1.6 | -1.2 | -2.5 | -3.6 | — |
BioRestorative Therapies, Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 4,079,635.0 | 12,279,799.0 | 12,611,720.0 | 16,434,691.0 | — |
| Total Liabilities | 3,722,891.0 | 3,748,406.0 | 2,607,345.0 | 6,144,352.0 | — |
| Total Equity | 356,744.0 | 8,531,393.0 | 10,004,375.0 | 10,290,339.0 | — |
Owes vs Owns
BioRestorative Therapies, Inc. owed $0.35 for every $1 it owned in Mar 2026, down from $0.37 in Dec 2022.
| Period | Mar 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.35× | 0.91× | 0.31× | 0.21× | 0.37× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
BioRestorative Therapies, Inc. Assets & Liabilities Breakdown (₹ Cr)
What it owns — Dec 2025
Cash & short-term investments 72.4%Fixed assets (tangible) 8.8%Intangible assets 13.1%Other assets 5.3%
How it's funded — Dec 2025
Payables 32.9%Other liabilities 58.4%Shareholders' equity 8.7%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 0.3 | 1.1 | 1.1 | 1.5 |
| Receivables | 0.0 | 0.0 | 0.0 | 0.0 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 0.0 | 0.0 | 0.1 | 0.1 |
| Intangible assets | 0.1 | 0.1 | 0.1 | 0.1 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Liabilities & equity | ||||
| Short-term debt | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term debt | 0.0 | 0.0 | 0.0 | 0.0 |
| Payables | 0.1 | 0.0 | 0.0 | 0.0 |
| Other liabilities | 0.2 | 0.3 | 0.2 | 0.6 |
| Shareholders' equity | 0.0 | 0.9 | 1.0 | 1.0 |
| Net tangible assets | -0.0 | 0.8 | 0.9 | 0.9 |
BioRestorative Therapies, Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -10,788,963.0 | -8,230,346.0 | -6,430,211.0 | -5,913,100.0 | — |
| Investing Activities | 8,897,470.0 | 514,529.0 | 3,252,043.0 | -13,399,855.0 | — |
| Financing Activities | 2,854,791.0 | 7,379,330.0 | 2,348,773.0 | 0.0 | — |